当前位置: X-MOL 学术Diabetes Obes. Metab. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Effectiveness of sodium-glucose co-transporter-2 inhibitors on ischaemic heart disease.
Diabetes, Obesity and Metabolism ( IF 5.8 ) Pub Date : 2020-03-12 , DOI: 10.1111/dom.14025
Yun Shen 1, 2 , Jian Zhou 1, 2 , Lizheng Shi 3 , Elizabeth Nauman 4 , Peter T Katzmarzyk 1 , Eboni G Price-Haywood 5 , Ronald Horswell 1 , San Chu 1 , Shengping Yang 1 , Alessandra N Bazzano 6 , Somesh Nigam 6 , Gang Hu 1
Affiliation  

To compare the cardiovascular risks between users and non‐users of sodium‐glucose co‐transporter‐2 (SGLT2) inhibitors based on electronic medical record data from a large integrated healthcare system in South Louisiana.

中文翻译:

钠葡萄糖共转运蛋白2抑制剂对缺血性心脏病的有效性。

根据南路易斯安那州大型综合医疗保健系统的电子病历数据,比较使用葡萄糖钠转运蛋白2(SGLT2)抑制剂的使用者和非使用者之间的心血管风险。
更新日期:2020-03-12
down
wechat
bug